These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12452752)

  • 1. Effect of soy milk on warfarin efficacy.
    Cambria-Kiely JA
    Ann Pharmacother; 2002 Dec; 36(12):1893-6. PubMed ID: 12452752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin-cranberry juice interaction.
    Hamann GL; Campbell JD; George CM
    Ann Pharmacother; 2011 Mar; 45(3):e17. PubMed ID: 21364039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orlistat enhances warfarin effect.
    MacWalter RS; Fraser HW; Armstrong KM
    Ann Pharmacother; 2003 Apr; 37(4):510-2. PubMed ID: 12659605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable Interaction Between Warfarin and Banana Flakes Supplement.
    King AE; Strnad K
    Nutr Clin Pract; 2016 Feb; 31(1):125-31. PubMed ID: 26137942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential interaction between telithromycin and warfarin.
    Kolilekas L; Anagnostopoulos GK; Lampaditis I; Eleftheriadis I
    Ann Pharmacother; 2004 Sep; 38(9):1424-7. PubMed ID: 15280511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to vitamin K antagonist revealing interaction with soy lecithin].
    Ksouda K; Affes H; Ghorbel A; Chtourou L; Guidara R; Tahri N; Hammami S; Zeghal K
    Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):98-100. PubMed ID: 29602443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that affect rate of INR decline after warfarin discontinuation.
    Burmester JK; Berg RL; Schmelzer JR; Mazza JJ; Yale SH
    WMJ; 2015 Feb; 114(1):16-20. PubMed ID: 25845131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan and warfarin interaction.
    Murphey LM; Hood EH
    Ann Pharmacother; 2003; 37(7-8):1028-31. PubMed ID: 12841813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.
    Marusic S; Gojo-Tomic N; Bacic-Vrca V; Franic M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):431-3. PubMed ID: 22677303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtherapeutic INR values associated with a switch to generic warfarin.
    Hope KA; Havrda DE
    Ann Pharmacother; 2001 Feb; 35(2):183-7. PubMed ID: 11215837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between warfarin and cranberry juice.
    Paeng CH; Sprague M; Jackevicius CA
    Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.